Atumida Incorporated

Atumida has developed a breakthrough protein therapeutic for the treatment of hemorrhagic shock.

  • Stage Not Set
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD
  • Employees 1
  • Website atumida.com

Company Summary

Team

  • Rob Burgess, PhD
    President and CEO

  • Richard Beswick, PhD, MBA
    Chairman of the Board

  • W. Roy Smythe, MD
    Chief Medical Officer

  • Ed Childs, MD
    Chief Scientific Officer

  • Rob Burgess

Advisors

  • Fulbright & Jaworski
    Lawyer
    Unconfirmed

Previous Investors

  • Scott & White Healthcare|The Texas A&M University System
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free